1 / 6

Lice Treatment Market

lice treatment market was valued at USD 93.47 million in 2021 and is expected to reach USD 156.44 million by 2029, registering a CAGR of 6.65% during the forecast period of 2022 to 2029.

Data57
Download Presentation

Lice Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lice Treatment - Industry Size, Growth, Trends and Forecast to 2029 Lice Treatment Market, By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other), Route of Administration (Oral, Topical, Others), Dosage Form (Tablets, Shampoos, lotions, cream, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) Browse Full Report : https://www.databridgemarketresearch.com/reports/global-lice-treatment-market

  2. Report Description Data Bridge Market Research analyses that the lice treatment market was valued at USD 93.47 million in 2021 and is expected to reach USD 156.44 million by 2029, registering a CAGR of 6.65% during the forecast period of 2022 to 2029. Get Details TOC : https://www.databridgemarketresearch.com/toc/?dbmr=global-lice-treatment-market

  3. Major Key Players • Some of the major players operating in this market are : • F. Hoffmann-La Roche Ltd. (Switzerland) • Mylan N.V. (US) • Teva Pharmaceutical Industries Ltd.(Israel) • Sanofi (France), Pfizer Inc. (US) • GlaxoSmithKline plc (UK) • Novartis AG (Switzerland) • AstraZeneca (UK) • Johnson & Johnson (US) • Bayer AG (Germany) Inquire Before Buying : https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lice-treatment-market

  4. Market Segmentation • By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others) • By Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other) • By Route of Administration (Oral, Topical, Others) • By Dosage Form (Tablets, Shampoos, lotions, cream, Others) • By End-Users (Hospitals, Specialty Clinics, Homecare, Others) Get Exclusive Sample Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lice-treatment-market

  5. Regional Analysis • Based on geography, the market is segmented into five geographical regions • North America • Europe • Asia-Pacific • South America • Middle East • Africa

  6. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com

More Related